Validation of a systemic lupus activity questionnaire (SLAQ) for population studies

Abstract

The goal of this work was to develop an economical way of tracking disease activity for large groups of systemic lupus erythematosus (SLE) patients in clinical studies. A Systemic Lupus Activity Questionnaire (SLAQ) was developed to screen for possible disease activity using items from the Systemic Lupus Activity Measure (SLAM) and tested for its measurement properties. The SLAQ was completed by 93 SLE patients just prior to a scheduled visit. At the visit, a rheumatologist, blinded to SLAQ results, examined the subject and completed a SLAM. Associations among SLAQ, and SLAM (omitting laboratory items) and between individual items from each instrument were assessed with Pearson correlations. Correlations between pairs of instruments were compared using Student’s t-tests. The mean score across all 24 SLAQ items was 11.5 (range 0 -33); mean SLAM without labs was 3.0 (range 0 -13). The SLAQ had a moderately high correlation with SLAM-nolab (r = 0.62, P < 0.0001). Correlations between patient-clinician matched pairs of items ranged from r = 0.06 to 0.71. Positive predictive values for the SLAQ ranged from 56 to 89% for detecting clinically significant disease activity. In studies of SLE, symptoms suggesting disease can be screened by self-report using the SLAQ and then verified by further evaluation.

Keywords

SLE disease activity self-assessment clinical trials clinimetrics outcome

Get full access to this article

View all access options for this article.

References

Karlson EW , Daltroy LH , Lew RA , Wright EA , Partridge AJ , Roberts WN et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 47-56 .

Smolen JS , Strand V , Cardiel M , Edworthy S , Furst D , Glasman D et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains . J Rheum 1999; 26: 504-505 .

Liang MH , Socher SA , Larson MG , Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus . Arthritis Rheum 1989; 32: 1107-1118 .

Bae SC , Koh H-K , Chang D-K , Kim M-H , Part J-K , Kim SY. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus . Lupus 2002; 10: 405-409 .

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35: 630-640 .

Hay EM , Bacon PA , Gordon C , Isenberg DA , Maddison P , Snaith ML et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus . Q J Med 1993; 86: 447-458 .

Petri M , Hellmann D , Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting . J Rheumatol 1992; 19: 53-59 .

Vitali C , Bencivelli W , Mosca M , Carrai P , Sereni M , Bombardieri S. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus . J Rheumatol 1999; 26: 498-501 .

Tan EM , Cohen AS , Fries JF , Masi AT , McShane DJ et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

10.

Karlson EW , Rivest C , Ramsey-Goldman R , Fortin PR , Shadick NA , Partridge AT , Lew RA , Wright EA , Daltroy LH , Liang MH. Validation of a self-administered SLE disease activity measure (SA-SLAM) for population studies . Arthritis Rheum 1996; 39: S209-S209 .

11.

Abrahamowicz M , Fortin PR , du Berger R , Nayak V , Neville C , Liang MH. The relationship between disease activity and expert physician’s decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials . J Rheum 1998; 25: 277-284 .

12.

Neville C , Clarke AE , Joseph L , Belisle P , Ferland D , Fortin P. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity . J Rheumatol 2000; 27: 675-679 .

13.

Chang ER , Abramowicz M , Ferland D , Fortin PR , for CaNIOS investigators . Organ manifestations influence differently the responsiveness of two lupus disease activity measures, according to patients’ or physicians’ evaluations of recent lupus activity . J Rheumatol 2002; 29: 2350-2358 .

14.

Nunnally JC , Bernstein IH. Psychometric Theory, 3rd edn. McGraw-Hill: New York . 1994.